TFF Pharmaceuticals (TFFP) Stock Chart & Stock Price History → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free TFFP Stock Alerts $2.11 -0.09 (-4.09%) (As of 11:06 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media TFF Pharmaceuticals Stock Price Performance5 Day Performance+3.94%1 Month Performance-50.47%3 Month Performance-70.18%6 Month Performance-64.83%Year-To-Date Performance-69.94%1 Year Performance-89.07% Receive TFFP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest TFFP Stock Chart for Wednesday, May, 8, 2024 TFFP Chart by TradingView TFF Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2024$2.16$2.20+1.85%$2.47$2.0646,086 shs$5.54 million05/06/2024$2.03$2.16+6.40%$2.30$1.9676,571 shs$5.44 million05/03/2024$2.47$2.03-17.81%$2.67$2.0184,522 shs$5.12 million05/02/2024$2.67$2.47-7.49%$2.83$2.4549,745 shs$6.22 million05/01/2024$2.73$2.67-2.20%$2.80$2.5646,773 shs$6.73 million04/30/2024$2.71$2.73+0.74%$2.84$2.5654,781 shs$6.88 million Get the Latest News and Ratings for TFFP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/29/2024$2.92$2.71-7.24%$3.18$2.6543,157 shs$6.83 million04/26/2024$3.05$2.92-4.26%$3.17$2.8034,088 shs$7.36 million04/25/2024$3.01$3.05+1.33%$3.10$2.9319,364 shs$7.68 million04/24/2024$3.03$3.01-0.50%$3.13$2.7912,712 shs$7.59 million04/23/2024$2.58$3.03+17.25%$3.14$2.5462,771 shs$7.62 million04/22/2024$3.11$2.58-17.04%$3.06$2.5147,266 shs$6.50 million04/19/2024$3.14$3.11-0.80%$3.41$3.113,671 shs$7.84 million04/18/2024$3.24$3.14-3.26%$3.47$3.0026,469 shs$7.90 million04/17/2024$3.31$3.24-2.10%$3.34$3.2021,779 shs$8.17 million04/16/2024$3.52$3.31-5.97%$3.47$3.2027,068 shs$8.34 million04/15/2024$3.85$3.52-8.57%$4.03$3.5032,246 shs$8.87 million04/12/2024$3.96$3.85-2.78%$4.26$3.8539,537 shs$9.70 million04/11/2024$4.07$3.96-2.70%$4.37$3.9212,035 shs$9.98 million04/10/2024$4.42$4.07-7.92%$4.59$3.9933,644 shs$10.26 million04/09/2024$4.26$4.42+3.76%$4.52$4.1918,775 shs$11.14 million04/08/2024$4.49$4.26-5.12%$4.61$4.2214,592 shs$10.74 million04/05/2024$4.83$4.49-7.04%$4.91$4.2543,128 shs$11.32 million04/04/2024$5.00$4.83-3.40%$5.27$4.6126,059 shs$12.17 million04/03/2024$4.93$5.00+1.42%$5.15$4.7437,802 shs$12.60 million04/02/2024$6.41$4.93-23.09%$6.34$4.84168,022 shs$11.68 million04/01/2024$6.04$6.41+6.13%$6.81$6.0542,294 shs$15.16 million03/29/2024$6.19$6.04-2.42%$7.17$5.9060,444 shs$14.32 million03/28/2024$6.59$6.19-6.07%$7.17$5.9060,427 shs$14.67 million03/27/2024$6.49$6.59+1.54%$6.85$5.9937,657 shs$15.62 million03/26/2024$7.40$6.49-12.30%$7.45$5.79115,677 shs$15.35 million03/25/2024$7.69$7.40-3.77%$7.99$7.0647,741 shs$17.54 million03/22/2024$8.21$7.69-6.33%$8.20$7.3042,539 shs$18.23 million03/21/2024$7.95$8.21+3.27%$8.25$7.3351,242 shs$19.42 million03/20/2024$8.87$7.95-10.37%$11.00$7.74273,059 shs$18.84 million03/19/2024$7.60$8.87+16.71%$9.74$7.9067,290 shs$21.02 million03/18/2024$7.37$7.60+3.12%$8.02$7.6015,813 shs$18.01 million03/15/2024$7.62$7.37-3.28%$7.90$7.3010,226 shs$17.47 million03/14/2024$7.81$7.62-2.43%$8.10$7.624,887 shs$18.06 million03/13/2024$7.81$7.81$8.91$7.812,053 shs$18.51 millionCould this Tiny Biotech End Disease Forever? (Ad)Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now.03/12/2024$8.50$7.81-8.12%$9.36$7.8113,601 shs$18.47 million03/11/2024$7.89$8.50+7.73%$8.55$7.657,205 shs$20.15 million03/08/2024$8.24$7.89-4.25%$8.34$7.787,593 shs$18.70 million03/07/2024$8.03$8.24+2.62%$8.45$7.9413,057 shs$19.49 million03/06/2024$8.62$8.03-6.84%$8.52$7.2218,895 shs$19.03 million03/05/2024$8.99$8.62-4.12%$9.78$7.8017,191 shs$20.43 million03/04/2024$6.75$8.99+33.23%$9.45$6.7082,494 shs$21.31 million03/01/2024$6.13$6.75+10.08%$6.76$6.2129,114 shs$15.99 million02/29/2024$6.15$6.13-0.33%$6.40$6.0031,718 shs$14.53 million02/28/2024$5.26$6.15+16.92%$6.15$5.3033,830 shs$14.58 million02/27/2024$5.76$5.26-8.68%$6.12$5.2337,553 shs$12.44 million02/26/2024$5.90$5.76-2.40%$5.94$5.765,574 shs$13.65 million02/23/2024$5.90$5.90$6.00$5.7112,127 shs$13.98 million02/22/2024$6.62$5.90-10.88%$6.72$5.8212,237 shs$13.95 million02/21/2024$6.54$6.62+1.22%$6.68$6.294,476 shs$15.69 million02/20/2024$6.94$6.54-5.76%$6.90$6.2616,529 shs$15.50 million02/19/2024$6.94$6.94$7.05$6.804,300 shs$16.45 million02/16/2024$7.03$6.95-1.14%$7.04$6.804,316 shs$16.47 million02/15/2024$6.84$7.03+2.78%$7.10$6.664,343 shs$16.66 million02/14/2024$6.56$6.84+4.27%$7.03$6.518,274 shs$16.21 million02/13/2024$7.29$6.56-10.01%$7.30$6.5626,001 shs$15.55 million02/12/2024$7.10$7.29+2.68%$7.36$6.7419,661 shs$17.24 million02/09/2024$7.08$7.10+0.35%$7.20$6.846,725 shs$16.83 million02/08/2024$7.20$7.08-1.74%$7.22$6.5315,003 shs$16.77 million02/07/2024$6.40$7.20+12.50%$7.29$6.2838,963 shs$17.06 million Related Companies: Adial Pharmaceuticals Stock Chart Enveric Biosciences Stock Chart Shuttle Pharmaceuticals Stock Chart Pulmatrix Stock Chart Cadrenal Therapeutics Stock Chart Xenetic Biosciences Stock Chart Ayala Pharmaceuticals Stock Chart Pasithea Therapeutics Stock Chart Lixte Biotechnology Stock Chart Vaccinex Stock Chart Receive TFFP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TFFP) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.